Abstract

Inflammation is a well-organized innate immune response that plays an important role during the pathogen attacks and mechanical injuries. The Toll-like receptors (TLR)/nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) is a major signal transduction pathway observed in RAW 264.7 macrophages during the inflammatory responses. Here, we investigated the anti-inflammatory effects of Octominin; a bio-active peptide developed from Octopus minor in RAW 264.7 macrophages in vitro. Octominin was found to inhibit lipopolysaccharides (LPS)-stimulated transcriptional activation of NF-κB in RAW 264.7 cells and dose-dependently decreased the mRNA expression levels of TLR4. Specifically, in silico docking results demonstrated that Octominin has a potential to inhibit TLR4 mediated inflammatory responses via blocking formation of TLR4/MD-2/LPS complex. We also demonstrated that Octominin could significantly inhibit LPS-induced secretion of pro-inflammatory cytokine (interleukin-β; IL-1β, IL-6, and tumor necrosis factor-α) and chemokines (CCL3, CCL4, CCL5, and CXCL10) from RAW 264.7 cells. Additionally, Octominin repressed the LPS-induced pro-inflammatory mediators including nitric oxide (NO), prostaglandin E2, inducible NO synthase, and cyclooxygenase 2 in macrophages. These results suggest that Octominin is a potential inhibitor of TLRs/NF-κB signal transduction pathway and is a potential candidate for the treatment of inflammatory diseases.

Highlights

  • Octopus minor (Sasaki, 1920) is a member of class Cephalopods and phylum Mollusca; known as the common long-arm octopus

  • According to in silico docking results, Octominin was buried in the pocket of the TLR4/myeloid differentiation factor 2 (MD-2) complex by interacting with amino acid sites located in the TLR4/MD-2 heterodimer

  • Our results indicated that Octominin could potently alleviate LPS-activated inflammation through Toll-like receptors (TLR)/NF-κB axis in RAW 264.7 cells

Read more

Summary

Introduction

Octopus minor (Sasaki, 1920) is a member of class Cephalopods and phylum Mollusca; known as the common long-arm octopus. Most of the studies conducted on O. minor have been limited to genome studies, co-culture techniques, and nutritional analysis; limited attention have been given to identify its bioactive properties such as anti-inflammatory, anticancer, and antioxidants. It is a well-known fact that the marine ecosystems represent a rich source of structurally unique and novel bioactive compounds from the perspective of potential therapeutic agents [5,6]. The sequence of the peptide, which was designated as Octominin, and was able to act as antimicrobial peptide too

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call